11.01.08
Springville, UT-based Nature’s Way Holding Company, a subsidiary of Germany-based Dr. Willmar Schwabe Pharmaceuticals, has reached an agreement with North Castle Partners, LLC to acquire all outstanding shares of Enzymatic Therapy, Green Bay, WI, pending approval of other shareholders. Schwabe Pharmaceuticals comprises six companies in Germany and more than 20 subsidiaries and joint ventures around the world. The initial focus of the deal will be to advance product development and bring more natural health solutions to market. “We believe the complementary product portfolios and marketing know-how of Enzymatic Therapy and Nature’s Way will significantly strengthen our presence in the U.S. market, which is one of Schwabe’s strategic key markets for future growth,” said Dr. Dirk Reischig, chairman and CEO of Schwabe Pharmaceuticals.